Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine

Detalles Bibliográficos
Autores principales: Xie, Fang, Huang, Mei, Lin, Xiansheng, Liu, Chenhai, Liu, Zhen, Meng, Futao, Wang, Chao, Huang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684641/
https://www.ncbi.nlm.nih.gov/pubmed/38017059
http://dx.doi.org/10.1038/s41598-023-48298-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684641/
https://www.ncbi.nlm.nih.gov/pubmed/38017059
http://dx.doi.org/10.1038/s41598-023-48298-9

Ejemplares similares